Cargando…

Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer?

BACKGROUND: Overall, ∼5% of patients show late normal-tissue damage after radiotherapy with a smaller number having a risk of radiation-induced heart disease. Although the data are conflicting, large studies have shown increased risks of cardiovascular disease (CVD) for irradiated patients compared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanteles, G A, Whitworth, J, Mills, J, Peat, I, Osman, A, McCann, G P, Chan, S, Barwell, J G, Talbot, C J, Symonds, R P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720242/ https://www.ncbi.nlm.nih.gov/pubmed/19603028 http://dx.doi.org/10.1038/sj.bjc.6605182

Ejemplares similares

The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes
por: Giotopoulos, G, et al.
Publicado: (2007)

A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy
por: Talbot, C J, et al.
Publicado: (2012)

Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia
por: Byrd, P J, et al.
Publicado: (2012)

Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021)

Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study
por: Szczawińska-Popłonyk, Aleksandra, et al.
Publicado: (2020)

Focal cutaneous telangiectasia in a young dog of probable congenital origin
por: Ueyama, Akira, et al.
Publicado: (2022)

Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy
por: Herrscher, H., et al.
Publicado: (2019)

Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia.
por: Ramsay, J., et al.
Publicado: (1998)

Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report
por: Folgori, Laura, et al.
Publicado: (2010)

Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015)

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
por: Shayeghi, M., et al.
Publicado: (1998)

Subacute Cutaneous Lupus Erythematosus Triggered by Radiotherapy
por: Kolm, I., et al.
Publicado: (2013)

Surgery and radiotherapy in the treatment of cutaneous melanoma
por: Testori, A., et al.
Publicado: (2009)

Severe Late Toxicity After Adjuvant Breast Radiotherapy in a Patient with a Germline Ataxia Telangiectasia Mutated Gene: Future Treatment Decisions
por: Dosani, Maryam, et al.
Publicado: (2017)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Purpura and erythema associated with cutaneous numbness and hyperesthesia
por: Dokic, Yelena, et al.
Publicado: (2020)

Purpuric patches and telangiectasias on the chest
por: Zusstone, Esther M., et al.
Publicado: (2020)

Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia
por: Judge, Sean James, et al.
Publicado: (2018)

Gender differences in hereditary hemorrhagic telangiectasia severity
por: Mora-Luján, J. M., et al.
Publicado: (2020)

Cutaneous ulceration and breast implant compromise after pulse dye laser for radiation-induced telangiectasias
por: Rossi, Anthony M., et al.
Publicado: (2017)

An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
por: Yeo, A.J., et al.
Publicado: (2021)

Unilateral Nevoid Telangiectasia: An Overlooked Entity
por: Sukanya, G, et al.
Publicado: (2022)

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
por: Chang-Claude, J, et al.
Publicado: (2009)

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
por: Shovlin, C. L., et al.
Publicado: (2019)

Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2021)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Late cutaneous effects of a local potent steroid during adjuvant radiotherapy for breast cancer
por: Ulff, Eva, et al.
Publicado: (2017)

Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab
por: Albitar, Hasan Ahmad, et al.
Publicado: (2020)

Hereditary Hemorrhagic Telangiectasia in a Sudanese Patient
por: Elawad, Omer Ali Mohamed Ahmed, et al.
Publicado: (2020)

Correction to: Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens
por: Sudahar, H., et al.
Publicado: (2012)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
por: Inskip, H M, et al.
Publicado: (1999)

Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
por: Chung, Joshua S., et al.
Publicado: (2022)

Bladder Wall Telangiectasia in a Patient with Ataxia-Telangiectasia and How to Manage?
por: Aygün, Fatma Deniz, et al.
Publicado: (2015)

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
por: Veenhuis, Stefanie J.G., et al.
Publicado: (2021)

Ataxia-telangiectasia mutated (ATM) gene mutation in a patient with primary cutaneous marginal zone lymphoma
por: Sarver, Melissa M., et al.
Publicado: (2022)

Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia–telangiectasia mutated gene)
por: Asadollahi, Reza, et al.
Publicado: (2020)

Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response
por: McCann, Emma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_djjhhqhq7vmdqk2r448je0ua10